UiPath (PATH)
NYSE:PATH
Top Page
UiPath
(NYSE:PATH)
Select Model
Select Model
Rating:74Outperform
Price Target:
$12.00
▲(9.79% Upside)
Action:ReiteratedDate:03/26/26
The score is driven primarily by strong financial quality (low leverage, improving profitability and free cash flow) and a supportive earnings outlook with margin and cash-flow targets. These positives are partially offset by weak technicals (price below key moving averages, negative MACD) and only moderate valuation support (P/E ~24 and no dividend).
Positive Factors
Conservative balance sheet
Very low leverage and a large equity base provide durable financial flexibility: supports investment in product, M&A, and buybacks while insulating operations from downturns. This conservatism reduces refinancing risk and underpins long-term strategy execution over the next 2–6 months.
Negative Factors
Decelerating revenue growth
A slowdown from high historical growth to single‑digit rates raises execution risk: sustaining margin improvements depends on expansion within large accounts and cost discipline. Slower top‑line makes hitting long‑term growth assumptions and margin targets harder without continued upsell success.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage and a large equity base provide durable financial flexibility: supports investment in product, M&A, and buybacks while insulating operations from downturns. This conservatism reduces refinancing risk and underpins long-term strategy execution over the next 2–6 months.
Read all positive factors
UiPath (PATH) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.84B
Dividend YieldN/A
Average Volume (3M)38.87M
Price to Earnings (P/E)24.0
Beta (1Y)1.29
Revenue Growth10.05%
EPS GrowthN/A
CountryUS
Employees3,868
SectorTechnology
Sector Strength88
IndustrySoftware - Infrastructure
Share Statistics
EPS (TTM)0.30
Shares Outstanding460,443,700
10 Day Avg. Volume45,870,018
30 Day Avg. Volume38,869,581
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)3.25
Price to Sales (P/S)4.21
P/FCF Ratio19.24
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue3.17
Enterprise Value/Gross Profit3.81
Enterprise Value/Ebitda68.20
Forecast
1Y Price Target
$13.47Price Target Upside23.24% Upside
Rating ConsensusHold
Number of Analyst Covering17
EPS Forecast (FY)0.77
Revenue Forecast (FY)$1.76B
UiPath Business Overview & Revenue Model
Company Description
UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run,...
How the Company Makes Money
UiPath primarily makes money by selling subscriptions to its automation software platform, typically under enterprise agreements that provide customers access to its automation capabilities (e.g., developing, running, and managing automated proces...
UiPath Key Performance Indicators (KPIs)
Any
Dollar-Based Net Retention Rate
Measures how much revenue growth or shrinkage comes from existing customers, indicating customer satisfaction and the company's ability to upsell or retain clients.
Measures how much revenue growth or shrinkage comes from existing customers, indicating customer satisfaction and the company's ability to upsell or retain clients.
Data provided by:
The Fly
The FlyUiPath Earnings Call Summary
Earnings Call Date:Mar 11, 2026
(Q4-2026)
| % Change Since: |
Next Earnings Date:Jun 03, 2026
Earnings Call Sentiment Positive
The call presented multiple strong operational and financial achievements: ARR and revenue growth, first full-year GAAP profitability, substantial non-GAAP margin expansion, robust cash generation, significant AI product traction (nearly $200M AI ARR), growing cloud ARR, and high retention rates. Management provided constructive guidance (FY27 ARR >$2B target, FY27 revenue guide, and increased long-term margin target to ~30%) while noting prudence due to macro variability and a modest SaaS mix headwind (~1%). Challenges include moderate overall growth rates (low double-digit ARR/revenue growth), the need to integrate tuck-in technology (WorkFusion) which is immaterial today, and competitive/market variability in the agentic AI space. Overall, the positives — profitability, cash generation, AI adoption inside the installed base, and clear product/vertical GTM momentum — materially outweigh the lowlights.Positive Updates
ARR Growth and Scale
Fourth quarter ARR of $1.853 billion, up 11% year-over-year; net new ARR of $70 million in the quarter; company expects to cross $2.0 billion ARR in fiscal 2027 (guidance: ARR $2.051B–$2.056B).
Negative Updates
Moderate Top-Line Growth Rate
ARR growth of 11% and full-year revenue growth of 13% (11% normalized) represent moderate expansion vs. high-growth software peers; net new ARR of $70M in the quarter signals stabilization rather than acceleration.
Read all updates
Q4-2026 Updates
Positive
Negative
ARR Growth and Scale
Fourth quarter ARR of $1.853 billion, up 11% year-over-year; net new ARR of $70 million in the quarter; company expects to cross $2.0 billion ARR in fiscal 2027 (guidance: ARR $2.051B–$2.056B).
Read all positive updates
Company Guidance
UiPath guided Q1 FY2027 revenue of $395–400M, ARR of $1.894–1.899B and non‑GAAP operating income of about $80M (basic shares ~525M), and for full FY2027 revenue of $1.754–1.759B, ARR of $2.051–2.056B and non‑GAAP operating income of ≈$415M; they expect fiscal‑year non‑GAAP gross margin of ~84% and non‑GAAP adjusted free cash flow of ≈$425M, first‑half revenue of ~ $795M with first‑half net new ARR ≈ $73M (seasonality similar to FY26 with ~30% of revenue in Q4 and Q4 as strongest quarter), a SaaS/cloud mix to create ~1% headwind to total revenue growth, FY2027 stock‑based compensation dilution of ~2–3% year‑over‑year (ex‑buyback), modest offsetting FX effects (yen headwind/euro tailwind, net immaterial), inclusion of an immaterial WorkFusion contribution, and a reiterated longer‑term goal of ~30% non‑GAAP operating margin and becoming meaningfully GAAP profitable in FY2027.UiPath Financial Statement Overview
Summary
Income Statement
73
Positive
Balance Sheet
88
Very Positive
Cash Flow
82
Very Positive
| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.61B | 1.43B | 1.31B | 1.06B | 892.25M |
| Gross Profit | 1.34B | 1.18B | 1.11B | 878.53M | 723.38M |
| EBITDA | 77.92M | -145.34M | -141.70M | -348.28M | -486.24M |
| Net Income | 282.33M | -73.69M | -89.88M | -328.35M | -525.59M |
Balance Sheet | |||||
| Total Assets | 3.18B | 2.87B | 2.95B | 2.74B | 2.57B |
| Cash, Cash Equivalents and Short-Term Investments | 1.47B | 1.63B | 1.88B | 1.76B | 1.87B |
| Total Debt | 70.94M | 77.82M | 67.07M | 63.44M | 51.40M |
| Total Liabilities | 1.10B | 1.02B | 938.64M | 815.05M | 650.53M |
| Stockholders Equity | 2.08B | 1.85B | 2.02B | 1.92B | 1.92B |
Cash Flow | |||||
| Free Cash Flow | 352.16M | 305.64M | 291.74M | -33.80M | -68.02M |
| Operating Cash Flow | 371.21M | 320.56M | 299.08M | -9.98M | -54.96M |
| Investing Cash Flow | -22.47M | -45.50M | -439.57M | -289.14M | -35.44M |
| Financing Cash Flow | -372.38M | -450.51M | -196.90M | -60.67M | 1.47B |
UiPath Technical Analysis
Negative
10.93
Price Trends
12.31
Negative
13.99
Negative
13.37
Negative
Market Momentum
-0.14
Negative
40.91
Neutral
32.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PATH, the sentiment is Negative. The current price of 10.93 is below the 20-day moving average (MA) of 11.55, below the 50-day MA of 12.31, and below the 200-day MA of 13.37, indicating a bearish trend. The MACD of -0.14 indicates Negative momentum. The RSI at 40.91 is Neutral, neither overbought nor oversold. The STOCH value of 32.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PATH.
UiPath Risk Analysis
UiPath disclosed 63 risk factors in its most recent earnings report. UiPath reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
UiPath Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $5.84B | 24.00 | 15.32% | ― | 10.05% | ― | |
71 Outperform | $4.07B | 21.93 | 15.43% | ― | 7.01% | 17.48% | |
70 Outperform | $19.81B | ― | -2.41% | ― | 20.93% | 68.47% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ― | ― | -26.98% | ― | 21.58% | 18.88% | |
58 Neutral | $4.55B | -10.24 | -29.84% | ― | 24.09% | -34.25% | |
54 Neutral | $2.51B | -38.13 | -27.04% | ― | 11.37% | -34.44% |
* Technology Sector Average
PATH
UiPath
10.93
0.06
0.55%
ACIW
ACI Worldwide
40.04
-15.13
-27.42%
VRNS
Varonis Systems
21.39
-20.30
-48.69%
MDB
MongoDB
246.54
57.90
30.69%
CFLT
Confluent
30.99
5.42
21.20%
S
SentinelOne
13.36
-5.99
-30.96%
UiPath Corporate Events
Business Operations and StrategyExecutive/Board Changes
UiPath Elevates Malpani to Chief Product and Technology Officer
Positive
Mar 25, 2026
On March 24, 2026, the UiPath board’s Compensation Committee appointed current Chief Technology Officer Raghavendra (Raghu) Malpani as Chief Product and Technology Officer, effective March 25, 2026, expanding his remit to oversee both produc...
Business Operations and StrategyStock BuybackFinancial DisclosuresM&A TransactionsProduct-Related Announcements
UiPath Delivers First Full-Year Profit and New Buyback
Positive
Mar 12, 2026
On March 11, 2026, UiPath reported fourth-quarter fiscal 2026 revenue of $481 million, up 14% year over year, and annual recurring revenue of $1.853 billion, up 11%, alongside GAAP operating income of $80 million in the quarter and $57 million for...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.